Cargando…
Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754065/ https://www.ncbi.nlm.nih.gov/pubmed/35022420 http://dx.doi.org/10.1038/s41408-021-00605-1 |
| _version_ | 1784632194574057472 |
|---|---|
| author | Morsink, L. M. van Doesum, J. Choi, G. Hazenberg, C. L. E. Biswana, A. Meppelink, F. Bungener, L. B. Lambeck, A. J. A. Huls, G. |
| author_facet | Morsink, L. M. van Doesum, J. Choi, G. Hazenberg, C. L. E. Biswana, A. Meppelink, F. Bungener, L. B. Lambeck, A. J. A. Huls, G. |
| author_sort | Morsink, L. M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8754065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87540652022-01-13 Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning Morsink, L. M. van Doesum, J. Choi, G. Hazenberg, C. L. E. Biswana, A. Meppelink, F. Bungener, L. B. Lambeck, A. J. A. Huls, G. Blood Cancer J Correspondence Nature Publishing Group UK 2022-01-12 /pmc/articles/PMC8754065/ /pubmed/35022420 http://dx.doi.org/10.1038/s41408-021-00605-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Morsink, L. M. van Doesum, J. Choi, G. Hazenberg, C. L. E. Biswana, A. Meppelink, F. Bungener, L. B. Lambeck, A. J. A. Huls, G. Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| title | Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| title_full | Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| title_fullStr | Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| title_full_unstemmed | Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| title_short | Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| title_sort | robust covid-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754065/ https://www.ncbi.nlm.nih.gov/pubmed/35022420 http://dx.doi.org/10.1038/s41408-021-00605-1 |
| work_keys_str_mv | AT morsinklm robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT vandoesumj robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT choig robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT hazenbergcle robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT biswanaa robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT meppelinkf robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT bungenerlb robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT lambeckaja robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning AT hulsg robustcovid19vaccinationresponseafterallogeneicstemcelltransplantationusingposttransplantationcyclophosphamideconditioning |